These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 18317302)

  • 21. Predictors of pathologic outcome of focal FDG uptake in the parotid gland identified on whole-body FDG PET imaging.
    Mabray MC; Behr SC; Naeger DM; Flavell RR; Glastonbury CM
    Clin Imaging; 2015; 39(6):1073-9. PubMed ID: 26324219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance.
    Loutfi I; Nair MK; Ebrahim AK
    J Nucl Med Technol; 2003 Jun; 31(2):81-5. PubMed ID: 12777459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidental diagnosis of tumor thrombosis on FDG PET/CT imaging.
    Erhamamci S; Reyhan M; Nursal GN; Torun N; Yapar AF
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):287-94. PubMed ID: 26025479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
    Kumar R; Hawkins RA; Yeh BM; Wang ZJ
    Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elastofibroma dorsi incidentally detected by (18)F-FDG PET/CT imaging.
    Erhamamci S; Reyhan M; Nursal GN; Torun N; Yapar AF; Findikcioglu A; Canpolat T
    Ann Nucl Med; 2015 Jun; 29(5):420-5. PubMed ID: 25666569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
    Danstrup CS; Lyhne NM; Kovacsne A; Fisker R; Zacho HD
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):357-364. PubMed ID: 35939059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence.
    Metser U; Miller E; Lerman H; Even-Sapir E
    AJR Am J Roentgenol; 2007 Nov; 189(5):1203-10. PubMed ID: 17954662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
    Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D
    J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
    J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results.
    Kei PL; Vikram R; Yeung HW; Stroehlein JR; Macapinlac HA
    AJR Am J Roentgenol; 2010 May; 194(5):W401-6. PubMed ID: 20410385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics.
    Davidson T; Komissar O; Goshen E; Shalmon B; Chikman B; Ben-Nun A; Ben-Haim S
    Nucl Med Commun; 2016 Sep; 37(9):969-74. PubMed ID: 27218431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
    Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography.
    Liu Y
    Ann Nucl Med; 2009 Jan; 23(1):17-23. PubMed ID: 19205834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.
    Czepczyński R; Stangierski A; Oleksa R; Janicka-Jedyńska M; Czarnywojtek A; Ruchała M; Sowiński J
    Nucl Med Rev Cent East Eur; 2011; 14(2):68-72. PubMed ID: 22474717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature.
    Treglia G; Calcagni ML; Rufini V; Leccisotti L; Meduri GM; Spitilli MG; Dambra DP; De Gaetano AM; Giordano A
    Colorectal Dis; 2012 Feb; 14(2):174-80. PubMed ID: 21689289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of
    Keraen J; Blanc E; Besson FL; Leguern V; Meyer C; Henry J; Belkhir R; Nocturne G; Mariette X; Seror R
    Arthritis Rheumatol; 2019 Jul; 71(7):1147-1157. PubMed ID: 30615273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology.
    Kang BJ; O JH; Baik JH; Jung SL; Park YH; Chung SK
    Ann Nucl Med; 2009 Oct; 23(8):729-37. PubMed ID: 19768518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary gland 18F-FDG-PET/CT uptake patterns in Sjögren's syndrome and giant cell arteritis patients.
    Grootelaar RGJ; van Ginkel MS; Nienhuis PH; Arends S; Pieterman RM; Brouwer E; Bootsma H; Glaudemans AWJM; Slart RHJA
    Clin Exp Rheumatol; 2023 Dec; 41(12):2428-2436. PubMed ID: 38079331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.